• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CVM advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of September 30, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20121071
Nov 201210100
Dec 201210100
Jan 201310100
Feb 201310100
Mar 201310100
Apr 201310100
May 201310100
Jun 201310100
Jul 201310100
Aug 201310100
Sep 201310100

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Number of CVM advisory committee member positions vacant at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2012N/A10
Nov 2012N/A14
Dec 2012N/A14
Jan 2013N/A14
Feb 2013N/A14
Mar 2013N/A14
Apr 2013N/A14
May 2013N/A14
Jun 2013N/A14
Jul 2013N/A14
Aug 2013N/A14
Sep 2013N/A14

Total number of CVM advisory committee member positions at the end of the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2012N/A14
Nov 2012N/A14
Dec 2012N/A14
Jan 2013N/A14
Feb 2013N/A14
Mar 2013N/A14
Apr 2013N/A14
May 2013N/A14
Jun 2013N/A14
Jul 2013N/A14
Aug 2013N/A14
Sep 2013N/A14

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.